Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Solventum Corporation (SOLV)
NYSE:SOLV
RESEARCH TOOLSreports
Solventum Corporation (SOLV) Stock Price & Analysis
105 Followers
SOLV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$47.35 - $96.05
Previous Close$49
Volume905.60K
Average Volume (3M)1.91M
Market Cap
$8.46B
Enterprise Value$8.27B
Total Cash (Recent Filing)$194.00M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.36
Next Earnings
Aug 08, 2024EPS Estimate
$1.51Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding172,709,505
10 Day Avg. Volume2,111,907
30 Day Avg. Volume1,910,738
Standard Deviation0.02
R-Squared1.00
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)1.10
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.76
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$60.50Price Target Upside25.47% Upside
Rating ConsensusHold
Number of Analyst Covering6
Solventum Corporation News
Bulls Say, Bears Say
Bulls Say
Growth ForecastSolventum (SOLV) shows potential for higher than expected growth in 2024, suggesting the stock is undervalued.
ManagementSOLV has a solid and well-known management team.
Market PotentialAttractive, large, diverse and growing markets represent an estimated $93 billion global industry with a 4-6% CAGR.
Bears Say
Financial ProjectionsCompany is not projected to reach a sustainable sales and earnings profile until 2028 with potential downward EPS revisions.
Investor SentimentThere has been a lack of support from potential new investors given SOLV’s public comments have focused on the negatives.
Operational ChallengesOngoing spin disruption and SKU rationalization could impact the company’s performance.
---
Ownership Overview
19.90% Insiders
2.04% Mutual Funds
20.74% Other Institutional Investors
57.31% Public Companies and Individual Investors
SOLV FAQ
What was Solventum Corporation’s price range in the past 12 months?
Solventum Corporation lowest stock price was $47.35 and its highest was $96.05 in the past 12 months.
What is Solventum Corporation’s market cap?
Currently, no data Available
When is Solventum Corporation’s upcoming earnings report date?
Solventum Corporation’s upcoming earnings report date is Aug 08, 2024 which is in 18 days.
How were Solventum Corporation’s earnings last quarter?
Solventum Corporation released its earnings results on May 09, 2024. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $1.745 by $0.335.
Is Solventum Corporation overvalued?
According to Wall Street analysts Solventum Corporation’s price is currently Undervalued.
Does Solventum Corporation pay dividends?
Solventum Corporation does not currently pay dividends.
What is Solventum Corporation’s EPS estimate?
Solventum Corporation’s EPS estimate is $1.51.
How many shares outstanding does Solventum Corporation have?
Solventum Corporation has 172,709,500 shares outstanding.
What happened to Solventum Corporation’s price movement after its last earnings report?
Solventum Corporation reported an EPS of $2.08 in its last earnings report, beating expectations of $1.745. Following the earnings report the stock price went down -2.409%.
Which hedge fund is a major shareholder of Solventum Corporation?
Currently, no hedge funds are holding shares in SOLV
---
Solventum Corporation Stock Smart Score
Company Description
Solventum Corporation
Solventum originates from two words: 'solving' and 'momentum.'Solving' captures the company's dedication to finding breakthrough solutions. The organization will listen closely to health care professionals and never stop solving for them -and the many lives they enhance globally. 'Momentum' symbolizes swifter, nimbler innovation. As the independent health care company builds on every achievement, large and small, its momentum propels it past barriers, towards breakthroughs. The new name represents how the independent health care company will focus on solving big health care challenges and emphasizes the tremendous impact it can make on the world.
---
SOLV Stock 12 Month Forecast
Average Price Target
$60.50
▲(25.47% Upside)
Technical Analysis
Best Analysts Covering SOLV
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+16.00%
initiated a sell rating 2 months ago
Copying David Roman's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +16.00% per trade.
---